75 Curado MP, Edward B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P, editors. IARC ScientificPublications No 160. Lyon: IARC; 2007. Cancer Incidence in Five Continents, Volume IX. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. (Accedido en: marzo 2018). Disponible en: http://globocan.iarc.fr Galceran J, Ameijide A, Carulla M, Mateos A, Quirós JR, Rojas D et al. Cancer incidence in Spain, 2015. Clin Transl Oncol. 2017 Jul;19(7):799-825. Stewart JH, Buccianti G, Agodoa L, Gellert R, McCredie MR, Lowenfels AB et al. Cancers of the Kidney and Urinary Tract in Patients on Dialysis for End-Stage Renal Disease: Analysis of Data from the United States, Europe, and Australia and New Zealand,. J Am Soc Nephrol .2003;14:197—207. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: Metaanalysis of 24 studies. Int J Cancer. 2005;114:101-8. Renehan AG, Soerjomataram I, Tyson M, Egger M, Zwahlen M, Coebergh JW, et al. Incident cancer burden attributable to excess body mass index in 30 european countries. Int J Cancer. 2010;126:692-702. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2006;118:728-38. McLaughlin JK, Chow WH, Mandel JS, Mellemgaard A, McCredie M, Lindblad P, et al. International renalcell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer. 1995;63(2):216-21. Gago-Domínguez M, Yuan M, Castelao JE, Ross RK, Yu MC. Regular use of analgesics is a risk factor for renal cell carcinoma. Br J Cancer. 1999;81:542-–548. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, PA. Lippincott, Williams & Watkins; 2011:1161–82:Ch93. Motzer RJ, Bacik J, Schwartz LH, Reuter V, Russo P, Marion S, et al. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol. 2004;22(3):454-63. Campbell et al. Guideline for management the clinical T1 renal mass. J Urol. (2009) ;182(4):1271-9. Chow WH, Devesa SS. Contemporary epidemiology of renal cell cancer. Cancer J. 2008;14(5):288-301. Ko JJ, Xie W, Kroeger N, Lee JL, Rini BI, Knox JJ, et al. The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study. Lancet Oncol. 2015;16(3):293-300. Wood SL, Brown JE. Skeletal metastasis in renal cell carcinoma: Current and future management options. Cancer Treatment Reviews. 2012; 38: 284–2-91. Patard JJ, Leray E, Rioux-Leclercq N, et al. Prognostic value of histologic subtypes in renal cell carcinomas: a multicenter experience. J Clin Oncol. 2005; 23:2763–2771. Escudier B, Porta C, Schmidinger M, Algaba F, Patard JJ, Khooet V, et al. Renal cell carcinoma:ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii49-iii56. Cooney MM, Remick SC, Vogelzang NJ. Promising systemic therapy for renal cell carcinoma. Curr Treat Options Oncol. 2005;6(5):357-65. American Joint Committee on Cancer (AJCC). Cancer Staging Handbook. 7th edition 2010. National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Kidney cancer. v2.2016. https://www.nccn.org. Ljungberg B, Bensalah K, Bex A, Canfield S, Dabestani S, Hofmann F, et al. Guidelines on renal cell carcinoma. EAU, 2014. http://uroweb.org/wp-content/uploads/10-Renal-Cell-Carcinoma_LR.pdf. Mekhail T, Abou-Jawde R, Boumerhi G, Malhi S, Wood L, Elson P, et al. Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. J Clin Oncol. 2005;23(4):832-41. Taal MW, et al., eEds. Brenner & Rector’s The Kidney. 9th ed. Philadelphia, PA: Elsevier, Saunders: 2012:1508-–35:Ch4. Patel PH, Chaganti RS, Motzer RJ. Targeted therapy for metastatic renal cell carcinoma. Br J Cancer.2006;94(5):614-9.